Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study ; volume:23 ; number:1 ; day:4 ; month:2 ; year:2023 ; pages:1-10 ; date:12.2023
BMC pulmonary medicine ; 23, Heft 1 (4.2.2023), 1-10, 12.2023
- Urheber
-
Lee, Jang Ho
Park, Hyung Jun
Kim, Seonok
Kim, Ye-Jee
Kim, Ho Cheol
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-023-02340-8
- URN
-
urn:nbn:de:101:1-2023040909043454415417
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Jang Ho
- Park, Hyung Jun
- Kim, Seonok
- Kim, Ye-Jee
- Kim, Ho Cheol
- SpringerLink (Online service)
Ähnliche Objekte (12)
Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study
Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management
Genome-wide assessment of shared genetic landscape of idiopathic pulmonary fibrosis and its comorbidities
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Smoking status and clinical outcome in idiopathic pulmonary fibrosis: a nationwide study
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities
Idiopathic pulmonary fibrosis: moving forward
Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study
Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study
Epidemiology of total hip arthroplasty: demographics, comorbidities and outcomes
Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study
Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management
Genome-wide assessment of shared genetic landscape of idiopathic pulmonary fibrosis and its comorbidities
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Smoking status and clinical outcome in idiopathic pulmonary fibrosis: a nationwide study
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities
Idiopathic pulmonary fibrosis: moving forward
Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study
Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study
Epidemiology of total hip arthroplasty: demographics, comorbidities and outcomes
Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study
Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management
Genome-wide assessment of shared genetic landscape of idiopathic pulmonary fibrosis and its comorbidities
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Smoking status and clinical outcome in idiopathic pulmonary fibrosis: a nationwide study
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities
Idiopathic pulmonary fibrosis: moving forward
Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study
Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study